Clinical Advancement Center, PLLC

The trials here

What the 16 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease14 trials
• Type 2 diabetes4 trials
• Heart failure1 trial
• High blood pressure1 trial
• Stroke1 trial
• Type 1 diabetes1 trial

Phase

• Phase 28 trials
• Phase 37 trials
• Phase 11 trial

Status

• Completed12 trials
• Active, not recruiting1 trial
• Suspended1 trial
• Terminated1 trial
• Withdrawn1 trial

Lead sponsor

• Bayer4 trials
• Boehringer Ingelheim2 trials
• Anji Pharma1 trial
• Disc Medicine, Inc1 trial
• Inversago Pharma Inc.1 trial
• and 7 more

Running trials

• Active, not recruiting

  Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

  NCT05099770· Phase 3· Prokidney· Source

Closed trials

• Completed

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

  NCT06926660· Phase 2· Boehringer Ingelheim· Source

• Withdrawn

  P2a Open Label Study to Evaluate 2-HPβCD in Subjects With Diabetic Kidney Disease

  NCT06489340· Phase 2· ZyVersa Therapeutics, Inc.· Source

• Completed

  A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

  NCT06522997· Phase 2· Bayer· Source

• Completed

  A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis

  NCT06218290· Phase 2· Unicycive Therapeutics, Inc· Source

• Completed

  A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis

  NCT05265325· Phase 2· Kind Pharmaceuticals LLC· Source

• Completed

  Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia

  NCT05745883· Phase 1· Disc Medicine, Inc· Source

• Completed

  A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease

  NCT05709444· Phase 2· Palatin Technologies, Inc· Source

• Completed

  Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

  NCT05514548· Phase 2· Inversago Pharma Inc.· Source

• Completed

  A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

  NCT05254002· Phase 2· Bayer· Source

• Completed

  Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

  NCT05085275· Phase 3· USRC Kidney Research· Source

• Terminated

  Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

  NCT04968184· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

  NCT05047263· Phase 3· Bayer· Source

• Completed

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· Phase 3· Bayer· Source

• Completed

  EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

  NCT03594110· Phase 3· Boehringer Ingelheim· Source